Securian Asset Management’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-3,835
Closed -$942K 944
2022
Q3
$942K Buy
3,835
+100
+3% +$27K 0.03% 456
2022
Q2
$924K Sell
3,735
-100
-3% -$27K 0.02% 530
2022
Q1
$1.27M Hold
3,835
0.02% 503
2021
Q4
$1.38M Sell
3,835
-64
-2% -$21.6K 0.03% 496
2021
Q3
$1.27M Sell
3,899
-100
-3% -$33.9K 0.03% 498
2021
Q2
$1.25M Sell
3,999
-100
-2% -$30.7K 0.03% 508
2021
Q1
$1.31M Hold
4,099
0.03% 486
2020
Q4
$1.33M Sell
4,099
-50
-1% -$13.8K 0.03% 473
2020
Q3
$1.15M Hold
4,149
0.03% 479
2020
Q2
$1M Sell
4,149
-270
-6% -$54.2K 0.03% 498
2020
Q1
$641K Sell
4,419
-100
-2% -$16.6K 0.02% 562
2019
Q4
$771K Sell
4,519
-281
-6% -$52.1K 0.02% 635
2019
Q3
$854K Buy
4,800
+100
+2% +$21.6K 0.02% 600
2019
Q2
$1.22M Hold
4,700
0.03% 495
2019
Q1
$1.34M Hold
4,700
0.03% 455
2018
Q4
$1.53M Hold
4,700
0.04% 381
2018
Q3
$2.11M Buy
4,700
+300
+7% +$118K 0.05% 331
2018
Q2
$1.8M Sell
4,400
-773
-15% -$280K 0.04% 372
2018
Q1
$1.5M Hold
5,173
0.04% 414
2017
Q4
$969K Sell
5,173
-125
-2% -$23.3K 0.02% 580
2017
Q3
$893K Buy
5,298
+114
+2% +$17.2K 0.02% 564
2017
Q2
$743K Hold
5,184
0.02% 611
2017
Q1
$649K Buy
5,184
+170
+3% +$19.7K 0.02% 658
2016
Q4
$565K Buy
5,014
+143
+3% +$16.6K 0.02% 696
2016
Q3
$626K Buy
4,871
+110
+2% +$13.2K 0.02% 636
2016
Q2
$520K Sell
4,761
-499
-9% -$49.6K 0.01% 679
2016
Q1
$499K Buy
+5,260
New +$444K 0.01% 711

Other funds holding ABMD

Securian Asset Management's ABMD Position: Q4 2022 in Review

Securian Asset Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 3,835 shares — an estimated $942K sold.

Securian Asset Management first reported a position in ABMD in Q1 2016 and held it in 27 quarters. The position peaked at $2.11M in Q3 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Securian Asset Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Securian Asset Management sold 3,835 Abiomed Inc shares in Q4 2022, an estimated $942K.
  • Securian Asset Management first reported a position in Abiomed Inc in Q1 2016 and held it in 27 quarters.
  • Securian Asset Management's Abiomed Inc position peaked at $2.11M in Q3 2018.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Securian Asset Management's 13F filing for Q4 2022, filed 3 Feb 2023.